Human mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+T-cell immune response-Reference-Cited by-同舟云学术

Human mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+T-cell immune response

Published:2004-02-03 Issue:6 Volume:109 Page:909-918
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Di Modugno Francesca,Bronzi Giovanna,Scanlan Matthew J.,Del Bello Duilia,Cascioli Simona,Venturo Irene,Botti Claudio,Nicotra Maria Rita,Mottolese Marcella,Natali Pier Giorgio,Santoni Angela,Jager Elke,Nisticò Paola

Funder

Italian Ministry of Health

Italian Association for Cancer Research

Consiglio Nazionale delle Ricerche-Ministero dell'Istruzione, dell'Università della Ricerca (CNR-MIUR)

Lega Italiana Lotta Tumori

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance;Marincola;Adv Immunol,2000

2. Cancer immunoediting: from immunosurveillance to tumor escape;Dunn;Nat Immunol,2002

3. Genetic changes occurring in established tumors rapidly stimulate new antibody responses;Spiotto;Proc Natl Acad Sci USA,2003

4. Human neoplasms elicit multiple specific immune responses in the autologous host;Sahin;Proc Natl Acad Sci USA,1995

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mammalian enabled protein enhances tamoxifen sensitivity of the hormone receptor-positive breast cancer patients by suppressing the AKT signaling pathway;Biology Direct;2024-03-08

2. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer;eBioMedicine;2024-03

3. A Hybrid Machine Learning Approach to Screen Optimal Predictors for the Classification of Primary Breast Tumors from Gene Expression Microarray Data;Diagnostics;2023-02-13

4. Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms;Pharmaceutics;2022-07-11

5. Resistance to Intervention: Paclitaxel in Breast Cancer;Mini-Reviews in Medicinal Chemistry;2021-05-19